Page last updated: 2024-11-05

thalidomide and Gall Bladder Diseases

thalidomide has been researched along with Gall Bladder Diseases in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HAGEN, EO1
Tweedle, D1

Other Studies

2 other studies available for thalidomide and Gall Bladder Diseases

ArticleYear
CONGENITAL MALFORMATIONS IN A THALIDOMIDE BABY: A POSTMORTEM ANATOMICAL STUDY.
    Canadian Medical Association journal, 1965, Feb-06, Volume: 92

    Topics: Abnormalities, Drug-Induced; Arm; Canada; Gallbladder Diseases; Infant; Kidney Diseases; Leg; Lung D

1965
Further problems with thalidomide.
    Journal of the Royal College of Surgeons of Edinburgh, 1990, Volume: 35, Issue:1

    Topics: Abdominal Pain; Diagnosis, Differential; Gallbladder; Gallbladder Diseases; Humans; Thalidomide

1990